Proxibarbital: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
No edit summary |
||
Line 37: | Line 37: | ||
{{barbiturates}} | {{barbiturates}} | ||
{{Hypnotics and sedatives}} | {{Hypnotics and sedatives}} | ||
{{SIB}} | |||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category:Sedatives]] | [[Category:Sedatives]] |
Revision as of 15:46, 2 July 2009
Clinical data | |
---|---|
Synonyms | Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H14N2O4 |
Molar mass | 226.229 g/mol |
WikiDoc Resources for Proxibarbital |
Articles |
---|
Most recent articles on Proxibarbital Most cited articles on Proxibarbital |
Media |
Powerpoint slides on Proxibarbital |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Proxibarbital at Clinical Trials.gov Trial results on Proxibarbital Clinical Trials on Proxibarbital at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Proxibarbital NICE Guidance on Proxibarbital
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Proxibarbital Discussion groups on Proxibarbital Patient Handouts on Proxibarbital Directions to Hospitals Treating Proxibarbital Risk calculators and risk factors for Proxibarbital
|
Healthcare Provider Resources |
Causes & Risk Factors for Proxibarbital |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Proxibarbital (Ipronal) is a barbiturate derivative invented in the 1970s. It has sedative, hypnotic and anticonvulsant properties, and was used in the treatment of migraine headaches in a similar manner to butalbital.[1]
References
- ↑ Sulman FG, Pfeifer Y, Tal E. Migraine therapy by enzyme induction with proxibarbital (German). Therapie die Gegenwart. 1976 Dec;115(12):2088-103.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Barbiturates
- Sedatives